Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
213M
-
Number of holders
-
511
-
Total 13F shares, excl. options
-
210M
-
Shares change
-
+12.3M
-
Total reported value, excl. options
-
$21.1B
-
Value change
-
+$1.36B
-
Put/Call ratio
-
1.22
-
Number of buys
-
293
-
Number of sells
-
-238
-
Price
-
$100.64
Significant Holders of INSMED Inc - Common stock, par value $0.01 per share (INSM) as of Q2 2025
613 filings reported holding INSM - INSMED Inc - Common stock, par value $0.01 per share as of Q2 2025.
INSMED Inc - Common stock, par value $0.01 per share (INSM) has 511 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 210M shares
of 213M outstanding shares and own 98.72% of the company stock.
Largest 10 shareholders include Darwin Global Management, Ltd. (19.3M shares), VANGUARD GROUP INC (17.6M shares), JPMORGAN CHASE & CO (15.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.2M shares), BlackRock, Inc. (11.1M shares), BAKER BROS. ADVISORS LP (7.71M shares), Capital International Investors (7.48M shares), FMR LLC (5.09M shares), STATE STREET CORP (4.28M shares), and D. E. Shaw & Co., Inc. (3.42M shares).
This table shows the top 511 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.